Omicron variant study could contribute to future vaccine development

  • December 13, 2022
Omicron variant study could contribute to future vaccine development

Antonia Netzl is co-author of a study on Covid variants which has implications for vaccine development

Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants.

Antonia Netzl et al

All the omicron strains are different from the original COVID infection and from each other, but repeated exposure to pre-omicron variants can protect against omicron variants, according to a new study which has implications for further vaccine development.

The study, BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants, is published in Nature Communications today and is co-authored by Gates Cambridge Scholar Antonia Netzl.

It looked at the original omicron variant [BA.1] and sought to compare whether the BA.2 and BA.5 sub-variants which soon replaced it in many countries were more resistant to COVID vaccines.

Using people with differing histories of exposure to infection and vaccination, they found that unvaccinated people had limited cross-neutralising antibodies to pre-omicron variants and BA.1 after a single exposure to BA.2.

By mapping all variants of concern and the omicron sub-variants, they showed that all the omicron sub-variants are distinct to pre-omicron variants, but that the three omicron variants are also antigenically distinct from each other.

Moreover, antibodies that can fight the virus are only generated after three or more exposures to antigenically close variants and also after two exposures to antigenically distant variants.

They say: “Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants. It suggests that cross-neutralisation improves with repeated exposure and an increase in absolute titers of antibodies and that exposure to two distant variants has protective potential against emerging variants with some degree of similarity to currently and previously circulating Variants of Concern.”

*Picture credit: https://www.vperemen.comCC BY-SA 4.0 and Wikimedia Commons.

 

Latest News

Exploring how the brain transforms thought into speech

Mac MacKay [2026] studies how the brain turns thought into speech. For him, that question is deeply personal. Born with verbal dyspraxia, he has spent years trying to understand the […]

Developing high quality, affordable diagnostic tests

Mitali Chowdhury [2026] discovered her passion for biotechnology early in her undergraduate studies and is dedicated to using it to create affordable, high quality public health products, such as diagnostic […]

New executive role for Ramit Debnath

Dr Ramit Debnath has been appointed Executive Director of the Centre for Human-Inspired Artificial Intelligence [CHIA]. Ramit [2018] is Assistant Professor at the University of Cambridge. He specialises in human-centric […]

How do we lead with courage in a world of Big Tech power?

Ella McPherson [2004] is Professor of the Sociology of Media and Technology and Co-Director of the Centre of Governance and Human Rights at the University of Cambridge. She will be […]